Artroniq Berhad (0038) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Artroniq Berhad stock MYR 0.10, price MYR 0.13, that is 18.4% below the price, quality 50 out of 100. Rating: overvalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
60‑month range 0.0600 MYR – 1.17 MYR · fair‑value band 0.0765 MYR – 0.1445 MYR · the 0.1250 MYR price screens above the 0.1020 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Follow Artroniq Berhad in your weekly email
Every Wednesday you see whether Artroniq Berhad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Artroniq Berhad, an investment holding company, provides trading of information and communication technology (ICT) products and related services, management services, and semiconductor in Malaysia, Asia, and the United States.
Show moreShow less
It is involved in the import, export, and distribution of information and communication technology products and related activities; manufacturing of polyethylene compound for wire and cable insulation and jacketing; compounding of plastic master batches, polymer additive, plastic compound and composites; provision of point of sales solutions and distribution of POS hardware, peripherals and related services; trading manufacturing and design of jig and fixture, precision tooling component; providing finance and investment consultation services; general trading, buying and selling of goods, import and export, modification, and repair works.
Artroniq Berhad was incorporated in 2002 and is based in Kuala Lumpur, Malaysia.
Stock analysis
Artroniq Berhad (0038) currently trades at 0.1250 MYR, while our model-based Fair Value estimate is 0.1020 MYR, 18% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 0.1300 MYR per share, and 2 of the 7 models we run sit above the 0.1250 MYR price.
Bear case: the Asset-Based group reads lowest at 0.0900 MYR, and 5 of the 7 models stay below the price. Data coverage for this calculation is low.
Scenario range: 0.0765 MYR (bear) to 0.1445 MYR (bull), the price of 0.1250 MYR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Technology sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Artroniq Berhad reported revenue of 10.4M MYR in FY2025 versus 269M MYR in FY2021, a compound −55.7%/yr. Reported net income was −7.4M MYR in FY2025.
Key figures
Market cap 63.5M MYR (≈ $15.7M) Micro · P/S ratio 4.82 · EPS (TTM) −0.0100 MYR · Dividend yield 1.3% · Net margin −71.4% · Return on equity −8.9% · Return on assets (EBIT) −9.6% (5-year average) · Operating margin 3.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (low confidence).
What moves the price
The share trades about 24% below its 52-week high and 39% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at 0% fair-value upside, at −18%, 0038 screens richer than that median.
Fair Value models
Bear0.0765 MYRFair Value 0.1020 MYRBull0.1445 MYR
Price 0.1250 MYR · Downside -18.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF0.1000 MYR0.1400 MYR0.1900 MYR81
Growth DCF0.1100 MYR0.1400 MYR0.1900 MYR80
5Y Revenue Exit0.0900 MYR0.1200 MYR0.1700 MYR73
All 7 models by family
DCF Models
FCF DCF0.1000 MYR0.1400 MYR0.1900 MYR81
5Y Revenue Exit0.0900 MYR0.1200 MYR0.1700 MYR73
10Y Revenue Exit0.0900 MYR0.1200 MYR0.1400 MYR68
Multiples
EV/Revenue0.0800 MYR0.1100 MYR0.1400 MYR54
Asset-Based
NCAV (Graham)0.0600 MYR0.0900 MYR0.1200 MYR54
Growth DCF
Growth DCF0.1100 MYR0.1400 MYR0.1900 MYR80
Rev-Margin DCF0.0900 MYR0.1200 MYR0.1600 MYR73
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.23/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−59.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−52.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−42.7%
Start year 2020 (pandemic). Over 10 years: −15.5% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−15.5%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1.9% (2020) → −61.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−0.4%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about −2.3% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronics & Computer Distribution · 151 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside−18.4% · Below median
Profitability
Return on assets−11.8% · Bottom 25%
Net margin (12 months)−47.8% · Bottom 25%
Operating margin (12 months)3.0% · Below median
Growth and dividend
Revenue growth (quarter YoY)69.7% · Top 25%
Dividend yield (12 months)1.3% · Below median
Valuation Multiplesvs Electronics & Computer Distribution median · lower = cheaper
P/B1.13× · Cheaper than median
P/S (12 months)4.81× · Priciest 25%
Price / free cash flow (fiscal year)13.0× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Artroniq Berhad Fair Value". https://www.fairvalue-calculator.com/stock/0038
Frequently asked questions
Is Artroniq Berhad (0038) overvalued or undervalued?
As of Nov 10, 2026, our model estimates a fair value of 0.1020 MYR versus a price of 0.1250 MYR, about 18% lower (overvalued).
What is the fair value of 0038?
Our model-based fair value for Artroniq Berhad is 0.1020 MYR (as of Nov 10, 2026), built from audited fundamentals. The current price: 0.1250 MYR.
What is the quality score of 0038?
Artroniq Berhad has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Artroniq Berhad (0038)?
Our model-based price target is the fair value of 0.1020 MYR (as of Nov 10, 2026) from 7 valuation models. Cautious scenario 0.0765 MYR, optimistic scenario 0.1445 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Artroniq Berhad stock forecast for 2026?
Our models put fair value at 0.1020 MYR, about 18% lower versus a price of 0.1250 MYR (overvalued). Cautious scenario 0.0765 MYR, optimistic scenario 0.1445 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Artroniq Berhad (0038)?
Artroniq Berhad reported trailing-twelve-month revenue of about 13.2M MYR (latest available figure, as of Nov 10, 2026).
Does Artroniq Berhad pay a dividend?
Artroniq Berhad currently shows a dividend yield of 1.33% relative to its recent price (as of Nov 10, 2026).
How much is the dividend of Artroniq Berhad (0038)?
Artroniq Berhad has a dividend yield of 1.3%.
What growth is priced into Artroniq Berhad (0038)?
For today's price to be fair in a discounted-cash-flow model, Artroniq Berhad would have to grow free cash flow by -0.4 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -42.7 % per year. As of Nov 10, 2026.
What discount rate (WACC) does the fair value of 0038 use?
Our models discount Artroniq Berhad at 9.7 %: a base by market capitalisation (nano), damped by beta 0.06, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Artroniq Berhad that is -0.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Artroniq Berhad (0038) delivered so far?
Over the past 5 years revenue at Artroniq Berhad grew -42.7 % a year. The price currently implies free-cash-flow growth of -0.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Artroniq Berhad (0038) growing?
The median revenue growth in the sector is +11.4 % a year. That is the yardstick for the growth priced into Artroniq Berhad (-0.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Artroniq Berhad (0038)?
The free-cash-flow yield on the price is 7.69 %: that much free cash flow Artroniq Berhad produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Artroniq Berhad (0038)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Artroniq Berhad it is 0.1020 MYR per share (as of Nov 10, 2026), against a price of 0.1250 MYR. It is the blended result of 7 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Artroniq Berhad stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 0038 trades above its calculated fair value: price 0.1250 MYR, fair value 0.1020 MYR, a gap of about −18% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0038?
No. The price is what the market pays today (0.1250 MYR); the fair value is what the company's own numbers justify (0.1020 MYR). For Artroniq Berhad the two are 0.0230 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Artroniq Berhad worth?
The market values Artroniq Berhad at about 63.5M MYR (market capitalisation, as of Nov 10, 2026). Per share that is 0.1250 MYR; our models calculate a fair value of 0.1020 MYR per share.
What do the bullish and bearish scenarios say about 0038?
Our models span a range for Artroniq Berhad: cautious scenario 0.0765 MYR, base 0.1020 MYR, optimistic 0.1445 MYR per share (as of Nov 10, 2026, price 0.1250 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Artroniq Berhad (0038)?
Balance-sheet figures for Artroniq Berhad (as of Nov 10, 2026): return on equity −8.9%. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is 0038 from its 52-week high?
Artroniq Berhad trades at 0.1250 MYR, about 24% below its 52-week high of 0.1650 MYR and 39% above the low of 0.0900 MYR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 0.1020 MYR is for.
Which stocks are comparable to Artroniq Berhad?
From the same area (Technology) we also value TD SYNNEX Corporation, Unisplendour Corporation, Arrow Electronics, Inc, Avnet, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Artroniq Berhad stock attractive at the current price?
The data as of Nov 10, 2026: price 0.1250 MYR, calculated fair value 0.1020 MYR (−18%), Quality Score 50/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0038 calculated?
We run Artroniq Berhad through 7 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of 0.1020 MYR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. Artroniq Berhad itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Artroniq Berhad (0038)?
The closing price on Nov 6, 2026 was 0.1250 MYR. Our model-based fair value is 0.1020 MYR, about 18% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Artroniq Berhad right now?
Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (0.0765 MYR to 0.1445 MYR) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Artroniq Berhad
How large is the market capitalisation of Artroniq Berhad (0038)?
The market capitalisation of Artroniq Berhad is 63.5M MYR (≈ $15.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Artroniq Berhad (0038)?
The price-to-sales ratio of Artroniq Berhad is 4.82 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Artroniq Berhad (0038)?
Earnings per share at Artroniq Berhad are −0.0100 MYR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Artroniq Berhad (0038)?
The dividend yield of Artroniq Berhad is 1.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Artroniq Berhad (0038)?
The net margin of Artroniq Berhad is −71.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Artroniq Berhad (0038)?
The return on equity (ROE) of Artroniq Berhad is −8.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Artroniq Berhad (0038)?
On an EBIT basis the return on assets of Artroniq Berhad is −9.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Artroniq Berhad (0038)?
The operating margin of Artroniq Berhad is 3.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Artroniq Berhad (0038)?
Revenue at Artroniq Berhad is growing +69.7% versus a year earlier (3y avg −52.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Artroniq Berhad (0038) hold?
Artroniq Berhad holds more cash than debt, 4.4M MYR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Artroniq Berhad in the live analysis
One click puts Artroniq Berhad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 10, 2026